节点文献

阿莫西林颗粒在中国健康人体内的生物等效性研究

Bioequivalence study of amoxicillin grains in healthy Chinese subjects

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 雷雨燕卢俊丽颜羽陈露露李晓晖陈维明夏曼李超欧阳冬生

【Author】 LEI Yu-yan;LU Jun-li;YAN Yu;CHEN Lu-lu;LI Xiao-hui;CHEN Wei-ming;XIA Man;LI Chao;OUYANG Dong-sheng;Phase Ⅰ Clinical Trial Laboratory,the Second Nanning People’s Hospital;Department of Pharmacology,Xiangya School of Pharmaceutical Science, Central South University;Changsha DUXACT Co.,Ltd.;Changsha Phamark Data Technology Co.,Ltd.;Hunan Key Laboratory for Bioanalysis of Complex Matrix Samples;

【通讯作者】 欧阳冬生;

【机构】 南宁市第二人民医院Ⅰ期临床试验研究室中南大学药学院长沙都正生物科技有限责任公司长沙砝码科数据科技有限责任公司复杂基质样本生物分析湖南省重点实验室

【摘要】 目的 研究阿莫西林颗粒在中国健康人体内的生物等效性。方法 采用单中心、随机、开放、单剂量、两制剂、两周期、双交叉试验设计。空腹试验和餐后试验中分别入组28例受试者,每周期口服阿莫西林颗粒受试制剂或参比制剂0.5 g。用LC-MS/MS法测定人血浆中阿莫西林的血药浓度,并用Phoenix WinNonlin 8.2软件计算主要药代动力学参数,进行生物等效性评价。结果 空腹试验受试制剂和参比制剂阿莫西林的主要药代动力学参数:Cmax分别为(11 222.19±2 497.11)和(10 919.47±2 282.44)ng·mL-1,AUC0-t分别为(27 238.73±3 324.23)和(26 288.06±2 904.36)h·ng·mL-1,AUC0-∞分别为(27 329.87±3 324.57)和(26 373.57±2 902.25)h·ng·mL-1,Tmax均为1.00 h。餐后试验受试制剂和参比制剂阿莫西林的主要药代动力学参数:Cmax分别为(7 210.34±1 072.25)和(7 140.64±1 175.17)ng·mL-1,AUC0-t分别为(27 840.59±3 112.02)和(27 133.23±2 930.17)h·ng·mL-1,AUC0-∞分别为(28 041.75±3 168.89)和(27 330.42±3 025.51)h·ng·mL-1,Tmax均为2.50 h。受试制剂与参比制剂Cmax、AUC0-t、AUC0-∞几何均值比的90%置信区间均在80.00%~125.00%内。结论 2种阿莫西林颗粒在中国健康受试者体内具有生物等效性。

【Abstract】 Objective To study the bioequivalence of amoxicillin grains in healthy Chinese subjects.Methods A single-center,randomized,open,single-dose,two-cycle,2*2 cross-over trial design was adopted.Under fasting and fedding conditions,28 healthy subjects were given amoxicillin grains test preparation 0.5 g (0.125 g×4 bags) or reference preparation 0.5 g orally.The plasma concentrations of amoxicillin at different time after treatment were detected by LC-MS/MS,and the main pharmacokinetic parameters were calculated by Phoenix Win Nonlin 8.2 to determine whether the two preparations were equivalent.Results The pharmacokinetic parameters of test preparation and reference preparation in fasting state were as follows:Cmaxwere(11 222.19±2 497.11) and (10 919.47±2 282.44) ng·mL-1;AUC0-t were (27 238.73±3 324.23) and (26 288.06±2 904.36) h·ng·mL-1;AUC0-∞were (27 329.87±3 324.57) and (26 373.57±2 902.25)h·ng·mL-1.Both of their Tmaxwere 1.00 h.The pharmacokinetic parameters of test preparation and reference preparation in postprandial state were as follows:Cmaxwere (7 210.34±1 072.25) and (7 140.64±1 175.17) ng·mL-1;AUC0-twere(27 840.59±3 112.02) and (27 133.23±2 930.17) h·ng·mL-1;AUC0-∞were (28 041.75±3 168.89) and(27 330.42±3 025.51) h·ng·mL-1.Both of their Tmaxwere 2.50 h.The 90%confidence intervals of the geometric mean ratios of Cmax,AUC0-tand AUC0-∞of the test preparation and the reference preparation were all completely within 80.00%-125.00%.Conclusion The test and reference preparations of amoxicillin were bioequivalent in Chinese healthy subjects.

【基金】 湖南省自然科学基金资助项目(2022JJ80100);复杂基质样本生物分析湖南省重点实验室基金资助项目(2017TP1037);湖南省复杂基质样本生物分析国际科技创新合作基地基金资助项目(2019CB1014)
  • 【文献出处】 中国临床药理学杂志 ,The Chinese Journal of Clinical Pharmacology , 编辑部邮箱 ,2023年18期
  • 【分类号】R969.1
  • 【下载频次】22
节点文献中: 

本文链接的文献网络图示:

本文的引文网络